Difference between revisions of "Part:BBa K364332:Experience"
| (2 intermediate revisions by the same user not shown) | |||
| Line 14: | Line 14: | ||
[[Image:Team Debrecen WB pSB1A3-TRE-Gal4-PXR-PolyA2.jpg|800px|thumb|center|Picture of Western blot: Gal4-PXR composite construct is highly expressed in the expression vector created from pSB1A3]] | [[Image:Team Debrecen WB pSB1A3-TRE-Gal4-PXR-PolyA2.jpg|800px|thumb|center|Picture of Western blot: Gal4-PXR composite construct is highly expressed in the expression vector created from pSB1A3]] | ||
| + | |||
| + | [[Image:PXR,_Ecr2.jpg|450px|thumb|center|Test of pCDNA/pSB1A3-GAL4-PXR/EcR-LBD activity]] | ||
| + | |||
| + | [[Image:Interact_3.jpg|400px|thumb|center|Test of PXR:RXR interaction]] | ||
===User Reviews=== | ===User Reviews=== | ||
Latest revision as of 07:59, 27 October 2010
This experience page is provided so that any user may enter their experience using this part.
Please enter
how you used this part and how it worked out.
Ligand
PXR is activated by a large number of endogenous and exogenous chemicals including steroids, antibiotics, antimycotics, bile acids, hyperforin, a constituent of the herbal antidepressant St. John's Wort, and many other herbal compounds.
PXR is activated by a range of compounds that induce CYP3A4, including dexamethasone and rifampicin.
Applications of BBa_K364332
User Reviews
UNIQa5ca30977f79474f-partinfo-00000000-QINU UNIQa5ca30977f79474f-partinfo-00000001-QINU